Before the Bell
$
98.50
Change
+0.38 +0.39%
Volume
Volume 12,792
Sep 27, 2023, 8:09 a.m.
Real time quotes
Previous close
$ 98.12
$ 98.12
Change
-0.05 -0.05%
Day low
Day high
$97.89
$99.62

52 week low
52 week high
$95.02
$217.25

Market cap
$37.36B
Average volume
4.06M
P/E ratio
36.05
Rev. per Employee
$2.71M
EPS
2.72
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on MRNA
-
Free Covid Tests Are Coming. Here's How to Get Yours.
- Janet H. Cho
-
The Covid Booster Rollout Is a Mess. That's Good News for Pfizer and Moderna.
- Josh Nathan-Kazis
-
New Cancer Drugs Are Changing the Odds of Survival
- Neal Templin
-
'This Is Not a Covid Vaccine Company,' Moderna CEO Says
- Josh Nathan-Kazis
-
Moderna Stock Rises on Positive Results From Flu Vaccine
- Angela Palumbo
-
Moderna aims to prove it’s ‘more than a COVID company’
- Eleanor Laise
-
Pfizer and Moderna Covid Vaccines Approved by FDA
- Josh Nathan-Kazis
-
New Pfizer and Moderna COVID shots approved by FDA
- Eleanor Laise
-
Pfizer and Moderna updated COVID vaccines approved by FDA
- Eleanor Laise
-
Immatics shares rise on Moderna cancer collaboration
- Eleanor Laise
- Loading more headlines...
Other News on MRNA
-
The Big Pharma Trade: Ozempic Is In, Covid-19 Is Out
- The Wall Street Journal Interactive Edition
-
Covid Boosters Aren’t Reaching People Who Want Them
- The Wall Street Journal Interactive Edition
-
The Score: Moderna, Splunk, Fox and More Stocks That Defined the Week
- The Wall Street Journal Interactive Edition
-
New Covid-19 Vaccines and More Free Mail-Order Tests. What to Know for This Fall.
- The Wall Street Journal Interactive Edition
-
A Game Plan for Timing Your Flu, Covid and RSV Shots This Fall
- The Wall Street Journal Interactive Edition
-
Stocks Tick Up in Quiet Session Ahead of Fed Decision
- The Wall Street Journal Interactive Edition
-
He’s Been Naming Covid Variants. Not Everyone’s Happy.
- The Wall Street Journal Interactive Edition
-
Stocks Edge Higher After No-Surprises Inflation Report
- The Wall Street Journal Interactive Edition
-
CDC Endorses Covid-19 Boosters for Everyone Aged 6 Months and Older
- The Wall Street Journal Interactive Edition
-
FDA Approves Newest Covid-19 Boosters
- The Wall Street Journal Interactive Edition
-
Biden Waves Through Another Covid Booster
- The Wall Street Journal Interactive Edition
-
‘Programmable Planet’ Review: Biology’s Big Bonus
- The Wall Street Journal Interactive Edition
-
A New Omicron Subvariant, Dubbed ‘Eris,’ Heralds Covid-19’s Resurgence
- The Wall Street Journal Interactive Edition
-
A New Omicron Subvariant, Dubbed ‘Eris,’ Heralds Covid-19’s Resurgence
- The Wall Street Journal Interactive Edition
-
Apple, Amazon, Starbucks to Report in Packed Earnings Week
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
Stocks Slip as Fed Minutes Reinforce Rate Expectations
- The Wall Street Journal Interactive Edition
-
Next Covid Shots in the U.S. Will Target Omicron Offshoot XBB.1.5
- The Wall Street Journal Interactive Edition
-
U.S. to Target XBB Strain When Covid Shots Roll Out This Fall
- The Wall Street Journal Interactive Edition
-
New Pfizer RSV Vaccine Rolls Out Into Headwinds of Hesitancy
- The Wall Street Journal Interactive Edition
- Loading more headlines...
Press Releases on MRNA
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com